Kynam Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kynam Capital Management LP
CRD #314368
SEC #801-126187
CIK #0001907884
AUM $2.6 B (2025-03-28)
Employees 3 (67% Investors, 0% Brokers)
Phone574-315-9016
Address
Source [IAPD] [EDGAR]
Total AUM ($B)
3.02.41.81.20.60.02011201620212026
CIK Period
0001907884
Sector Form 13F Holdings Value ($M)
Celldex Therapeutics Inc 124.1
Vaxcyte Inc 99.9
Vera Therapeutics Inc 80.7
Syndax Pharmaceuticals Inc 79.8
Biocryst Pharmaceuticals Inc 75.8
CG Oncology Inc 63.9
Signal Genetics Inc 61.9
UNUM Therapeutics Inc 61.0
Beam Therapeutics Inc 41.1
Immunocore Holdings PLC 30.6
Wave Life Sciences Ltd 29.6
Desert Gateway Inc 22.8
TYRA Biosciences Inc 22.3
Dynavax Technologies Corp 21.3
Engene Holdings Inc 18.2
Cullinan Oncology Inc 15.8
Nurix Therapeutics Inc 13.4
Relay Therapeutics Inc 10.0
Amarin Corp PLC UK 9.3
UroGen Pharma Ltd 9.0
CytomX Therapeutics Inc 4.9
Geron Corp 4.9
Ironwood Pharmaceuticals Inc 3.9
Caribou Biosciences Inc 3.9
Sutro Biopharma Inc 3.6
Design Therapeutics Inc 3.5
Proqr Therapeutics NV 3.4
Edgewise Therapeutics Inc 3.3
Liquidia Corp 2.5
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold ($M) AUM ($M)
HF Kynam Global Healthcare Master Fund LP [2021-04-12] 64.7 2,176.0
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 6 2.6
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 6 2.6
By Discretionary
Discretionary 6 2.6
Non-Discretionary 0 0.0
Total 6 2.6
By Non-United States Persons
Non-United States Persons 1.6
United States Persons 0.9
Total 6 2.6
Form D Directors # Filings # Firms 2011 - 2025
Robert Meschi 126
Richard Ruffer 361
Yue Tang 2
Kynam Capital Management LP 2
EDGAR Form CIK 2011 - 2025
13F-HR [0001907884]
3 [0001907884]
4 [0001907884]
SC 13G [0001907884]
Form 13D/13G Filer Form 13D/13G Subject Filed
Kynam Capital Management LP Vera Therapeutics Inc [2025-08-14]
Kynam Capital Management LP Sutro Biopharma Inc [2025-05-15]
Kynam Capital Management LP Viridian Therapeutics Inc de [2025-05-15]
Kynam Capital Management LP Engene Holdings Inc [2025-02-14]
Kynam Capital Management LP Dynavax Technologies Corp [2024-11-14]
Kynam Capital Management LP Syndax Pharmaceuticals Inc [2024-02-14]
Kynam Capital Management LP Celldex Therapeutics Inc [2024-02-14]
Kynam Capital Management LP Cogent Biosciences Inc [2024-02-14]
Kynam Capital Management LP Morphosys AG [2024-02-14]
Kynam Capital Management LP Burning Rock Biotech Ltd [2024-01-10]
View All
Form 3/4/5 Subject 2011 - 2025
2seventy bio, Inc.
Kynam Capital Management GP, LLC
Kynam Global Healthcare Master Fund, LP
Kynam Fund GP, LLC
Kynam Capital Management, LP
Tang Yue
Comparable Firms State AUM ($B)
Sourcerock Group LLC
CO 2.6
Sound Point Commercial Real Estate Finance LLC
NY 2.6
Pointer Management LLC
TN 2.6
Steelhead Partners LLC
WA 2.6
Bain Capital Partnership Strategies LP
MA 2.6
HITE Hedge Asset Management LLC
MA 2.6
Park West Asset Management LLC
CA 2.5
Concentric Capital Strategies LP
CT 2.5
Row Asset Management LLC
CA 2.5
Burkehill Global Management LP
NY 2.5
Terms | Privacy | Guide
tony@aum13f.com